Skip to main content
SpringerLink
Log in

A patient with refractory nephrotic syndrome withdrawn from peritoneal dialysis

  • Case Report
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

A 67-year-old woman was admitted to our hospital because of anasarca due to refractory nephrotic syndrome and chronic renal insufficiency. Laboratory data indicated serum total protein of 4.8 g/dl, albumin of 1.5 g/dl, creatinine of 1.9 mg/dl and BUN of 17 mg/dl. Urinary protein excretion was 7.8 g/day. Because of severe atrophy of both kidneys, neither renal biopsy nor immunosuppressive treatment was performed. Since conservative management including bed rest, diet therapy, limitation of water intake and administration of diuretics was not effective, peritoneal dialysis therapy using icodextrin only at night was started. The amount of water removal was steadily secured without progressing renal dysfunction or decreasing urine volume. From day 290 onward, the urinary protein excretion was decreased to show complete remission and urine volume increased. On day 528, peritoneal dialysis was discontinued, and thereafter only peritoneal lavage was performed. On day 858, the catheter was removed from the abdominal cavity, and thereafter diuretics could be discontinued. The reason for the dramatic reduction of urinary protein in this patient is unclear. However, it is possible that the primary disease such as membranous nephritis showed remission while the patient was undergoing icodextrin peritoneal dialysis, which preserves renal function but not extracorporeal ultrafiltration or hemodialysis. Icodextrin peritoneal dialysis may be an alternative to hemodialysis for refractory fluid overload in patients with nephrotic syndrome and may have the advantage of preserving renal function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65(4):1400–7.

    Article  PubMed  Google Scholar 

  2. Vasudevan A, Mantan M, Bagga A. Management of edema in nephrotic syndrome. Indian Pediatr. 2004;41(8):787–95.

    PubMed  Google Scholar 

  3. Morimoto S, Takahashi N, Kikuchi S, Yamahara H, Imada T, Kohno K, et al. Management of patients with recurrent nephrosis and intractable edema by intraperitoneal instillation of icodextrin solution. Perit Dial Int. 2008;28(5):559–62.

    CAS  PubMed  Google Scholar 

  4. Okada K, Maruyama N, Oikawa O, Yamazaki T, Higuchi T, Matsumoto K. Intracorporeal ultrafiltration with icodextrin for the treatment of severe overhydration. Perit Dial Int. 2005;25(5):503.

    CAS  PubMed  Google Scholar 

  5. Dallas F, Jenkins SB, Wilkie ME. Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study. Perit Dial Int. 2004;24(6):542–6.

    PubMed  Google Scholar 

  6. Kuriyama S, Otsuka Y, Iida R, Matsumoto K, Hosoya T. Icodextrin with small and short dwell enhances ultrafiltration in peritoneal dialysis patients with severe overhydration. Perit Dial Int. 2006;26(4):508–9.

    CAS  PubMed  Google Scholar 

  7. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol. 2003;14(9):2338–44.

    Article  CAS  PubMed  Google Scholar 

  8. Adachi Y, Nakagawa Y, Nishio A. Icodextrin preserves residual renal function in patients treated with automated peritoneal dialysis. Perit Dial Int. 2006;26(3):405–7.

    CAS  PubMed  Google Scholar 

  9. Davies SJ, Garcia Lopez E, Woodrow G, Donovan K, Plum J, Williams P, et al. Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange. Nephrol Dial Transpl. 2008;23(9):2982–8.

    Article  CAS  Google Scholar 

  10. Goldstein A, Kliger AS, Finkelstein FO. Recovery of renal function and the discontinuation of dialysis in patients treated with continuous peritoneal dialysis. Perit Dial Int. 2003;23(2):151–6.

    PubMed  Google Scholar 

  11. Bertoli SV, Ciurlino D, Maccario M, Martino S, Bigatti G, Traversi L, et al. Home peritoneal ultrafiltration in patients with severe congestive heart failure without end-stage renal disease. Adv Perit Dial. 2005;21:123–7.

    PubMed  Google Scholar 

  12. Basile C, Chimienti D, Bruno A, Cocola S, Libutti P, Teutonico A, et al. Efficacy of peritoneal dialysis with icodextrin in the long-term treatment of refractory congestive heart failure. Perit Dial Int. 2009;29(1):116–8.

    CAS  PubMed  Google Scholar 

  13. Foggensteiner L, Baylis J, Moss H, Williams P. Timely initiation of dialysis—single-exchange experience in 39 patients starting peritoneal dialysis. Perit Dial Int. 2002;22(4):471–6.

    PubMed  Google Scholar 

  14. Jeloka TK. “Icodextrin alone” for initiation of peritoneal dialysis. Perit Dial Int. 2008;28(5):563–4.

    CAS  PubMed  Google Scholar 

  15. Venturoli D, Jeloka TK, Ersoy FF, Rippe B, Oreopoulos DG. The variability in ultrafiltration achieved with icodextrin, possibly explained. Perit Dial Int. 2009;29(4):415–21.

    CAS  PubMed  Google Scholar 

  16. Moberly JB, Mujais S, Gehr T, Hamburger R, Sprague S, Kucharski A, et al. Pharmacokinetics of icodextrin in peritoneal dialysis patients. Kidney Int Suppl 2002. (81):S23–33.

  17. Mistry CD, Gokal R. Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis? The role for ‘colloid’ osmosis. Clin Sci (Lond). 1993;85(4):495–500.

    CAS  Google Scholar 

  18. Rippe B, Levin L. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD. Kidney Int. 2000;57(6):2546–56.

    Article  CAS  PubMed  Google Scholar 

  19. Davies D. Kinetics of icodextrin. Perit Dial Int. 1994;14(Suppl 2):S45–50.

    Google Scholar 

  20. Mistry CD, Mallick NP, Gokal R. Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges. Lancet. 1987;2(8552):178–82.

    Article  CAS  PubMed  Google Scholar 

  21. Wang T, Heimburger O, Cheng HH, Bergstrom J, Lindholm B. Peritoneal fluid and solute transport with different polyglucose formulations. Perit Dial Int. 1998;18(2):193–203.

    CAS  PubMed  Google Scholar 

  22. Wang T, Cheng HH, Heimburger O, Waniewski J, Bergstrom J, Lindholm B. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution. Kidney Int. 2000;57(4):1704–12.

    Article  CAS  PubMed  Google Scholar 

  23. de Waart DR, Zweers MM, Struijk DG, Krediet RT. Icodextrin degradation products in spent dialysate of CAPD patients and the rat, and its relation with dialysate osmolality. Perit Dial Int. 2001;21(3):269–74.

    PubMed  Google Scholar 

  24. Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int. 1994;46(2):496–503.

    Article  CAS  PubMed  Google Scholar 

  25. Mistry CD, Gokal R. Icodextrin in peritoneal dialysis: early development and clinical use. Perit Dial Int. 1994;14(Suppl 2):S13–21.

    Google Scholar 

  26. Posthuma N, ter Wee PM, Donker AJ, Oe PL, van Dorp W, Peers EM, et al. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell. Perit Dial Int. 1997;17(6):602–7.

    CAS  PubMed  Google Scholar 

  27. Posthuma N, ter Wee PM, Donker AJ, Oe PL, Peers EM, Verbrugh HA. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group. Perit Dial Int. 2000;Suppl 20(2):S106–13.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Internal Medicine, Kansai Medical University, 2-3-1 Shin-machi, Hirakata, Osaka, 573-1191, Japan

    Satoshi Morimoto, Nobuyuki Takahashi, Kazunori Someya, Tatsuyori Morita, Fusakazu Jo, Nagaoki Toyoda, Atsushi Kosaki, Mitsushige Nishikawa & Toshiji Iwasaka

Authors
  1. Satoshi Morimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nobuyuki Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazunori Someya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tatsuyori Morita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fusakazu Jo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nagaoki Toyoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Atsushi Kosaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mitsushige Nishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Toshiji Iwasaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Satoshi Morimoto.

About this article

Cite this article

Morimoto, S., Takahashi, N., Someya, K. et al. A patient with refractory nephrotic syndrome withdrawn from peritoneal dialysis. Clin Exp Nephrol 14, 363–366 (2010). https://doi.org/10.1007/s10157-010-0271-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-010-0271-6

Keywords

Search

Navigation